Literature DB >> 12464279

Phosphorylation of microtubule-associated protein tau by Ca2+/calmodulin-dependent protein kinase II in its tubulin binding sites.

Hideyuki Yamamoto1, Emiko Yamauchi, Hisaaki Taniguchi, Tsunehiko Ono, Eishichi Miyamoto.   

Abstract

The paired helical filaments (PHF) found in Alzheimer's disease (AD) brain are composed mainly of the hyperphosphorylated form of microtubule-associated protein tau (PHF-tau). It is well known that tau is a good in vitro substrate for Ca(2+)/calmodulin-dependent protein kinase II (CaM kinase II). To establish the phosphorylation sites, the longest human tau (hTau40) was bacterially expressed and phosphorylated by CaM kinase II, followed by digestion with lysyl endoprotease. The digests were subjected to liquid chromatography/mass spectrometry. We found that 5 of 22 identified peptides were phosphorylated. From the tandem mass spectrometry, two phosphorylation sites (serines 262 and 356) were identified in the tubulin binding sites. When tau was phosphorylated by CaM kinase II, the binding of tau to taxol-stabilized microtubules was remarkably impaired. As both serines 262 and 356 are reportedly phosphorylated in PHF-tau, CaM kinase II may be involved in hyperphosphorylation of tau in AD brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464279     DOI: 10.1016/s0003-9861(02)00556-8

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.

Authors:  Ahmed Ashour Ahmed; Xiaoyan Wang; Zhen Lu; Juliet Goldsmith; Xiao-Feng Le; Geoffrey Grandjean; Geoffrey Bartholomeusz; Bradley Broom; Robert C Bast
Journal:  Cancer Res       Date:  2011-07-20       Impact factor: 12.701

Review 2.  Making the cut: the chemical biology of cytokinesis.

Authors:  G Ekin Atilla-Gokcumen; Adam B Castoreno; Sofia Sasse; Ulrike S Eggert
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

3.  Interactions of the NPXY microdomains of the low density lipoprotein receptor-related protein 1.

Authors:  Miklos Guttman; Gina N Betts; Helen Barnes; Majid Ghassemian; Peter van der Geer; Elizabeth A Komives
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

4.  Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro.

Authors:  Jhoana Mendoza; Michiko Sekiya; Taizo Taniguchi; Koichi M Iijima; Rong Wang; Kanae Ando
Journal:  J Proteome Res       Date:  2013-04-26       Impact factor: 4.466

5.  Calmodulin Binding Proteins and Alzheimer's Disease.

Authors:  Danton H O'Day; Kristeen Eshak; Michael A Myre
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 6.  The role of Ca2+ signaling in Parkinson's disease.

Authors:  Sofia V Zaichick; Kaitlyn M McGrath; Gabriela Caraveo
Journal:  Dis Model Mech       Date:  2017-05-01       Impact factor: 5.758

7.  IL-33 suppresses GSK-3β activation through an ST2-independent MyD88/TRAF6/RIP/PI3K/Akt pathway.

Authors:  Tomoyuki Nishizaki
Journal:  Heliyon       Date:  2018-11-26

8.  Map7D2 and Map7D1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells.

Authors:  Koji Kikuchi; Yasuhisa Sakamoto; Akiyoshi Uezu; Hideyuki Yamamoto; Kei-Ichiro Ishiguro; Kenji Shimamura; Taro Saito; Shin-Ichi Hisanaga; Hiroyuki Nakanishi
Journal:  Life Sci Alliance       Date:  2022-04-25

9.  High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation.

Authors:  David O Azorsa; RiLee H Robeson; Danielle Frost; Bessie Meec hoovet; Gillian R Brautigam; Chad Dickey; Christian Beaudry; Gargi D Basu; David R Holz; Joseph A Hernandez; Kristen M Bisanz; Leslie Gwinn; Andrew Grover; Joseph Rogers; Eric M Reiman; Michael Hutton; Dietrich A Stephan; Spyro Mousses; Travis Dunckley
Journal:  BMC Genomics       Date:  2010-01-12       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.